×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
INKT – mink therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
INKT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/20
11:42 am
inkt
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors
Medium
Report
MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors
11/14
07:08 pm
inkt
MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation [Yahoo! Finance]
Medium
Report
MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation [Yahoo! Finance]
11/14
07:30 am
inkt
MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation
Low
Report
MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation
11/7
09:00 am
inkt
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
Medium
Report
MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025
11/5
09:07 am
inkt
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development
Low
Report
MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development
10/30
09:35 am
inkt
MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting [Yahoo! Finance]
Low
Report
MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting [Yahoo! Finance]
10/30
09:00 am
inkt
MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
Low
Report
MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
10/25
12:09 pm
inkt
MiNK Therapeutics (NASDAQ:INKT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
MiNK Therapeutics (NASDAQ:INKT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/3
04:10 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: WIINBERG ULF
High
Report
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: WIINBERG ULF
12/3
04:10 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Behner Peter
High
Report
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Behner Peter
12/3
04:10 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Kadlec Robert Peter
High
Report
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Kadlec Robert Peter
12/3
04:10 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Holcomb John Bradley
High
Report
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Holcomb John Bradley
12/3
04:10 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Ryan Barbara
High
Report
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Ryan Barbara
12/3
04:10 pm
inkt
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Corvese Brian
High
Report
Form 4 MiNK Therapeutics, Inc. For: Dec 01 Filed by: Corvese Brian
11/14
04:10 pm
inkt
Form 10-Q MiNK Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q MiNK Therapeutics, Inc. For: Sep 30
11/7
04:57 pm
inkt
Form S-3 MiNK Therapeutics, Inc.
Medium
Report
Form S-3 MiNK Therapeutics, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: